Correlation Between Goldman Sachs and Balter Invenomic

Can any of the company-specific risk be diversified away by investing in both Goldman Sachs and Balter Invenomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goldman Sachs and Balter Invenomic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Goldman Sachs Inflation and Balter Invenomic Fund, you can compare the effects of market volatilities on Goldman Sachs and Balter Invenomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goldman Sachs with a short position of Balter Invenomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goldman Sachs and Balter Invenomic.

Diversification Opportunities for Goldman Sachs and Balter Invenomic

0.01

Correlation Coefficient

Goldman Sachs  Balter Invenomic

Significant diversification

The 3 months correlation between Goldman and Balter is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Goldman Sachs Inflation and Balter Invenomic Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Balter Invenomic and Goldman Sachs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goldman Sachs Inflation are associated (or correlated) with Balter Invenomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Balter Invenomic has no effect on the direction of Goldman Sachs i.e., Goldman Sachs and Balter Invenomic go up and down completely randomly.

Pair Corralation between Goldman Sachs and Balter Invenomic

Assuming the 90 days horizon Goldman Sachs Inflation is expected to under-perform the Balter Invenomic. But the mutual fund apears to be less risky and, when comparing its historical volatility, Goldman Sachs Inflation is 2.68 times less risky than Balter Invenomic. The mutual fund trades about -0.11 of its potential returns per unit of risk. The Balter Invenomic Fund is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,723  in Balter Invenomic Fund on September 14, 2024 and sell it today you would earn a total of  11.00  from holding Balter Invenomic Fund or generate 0.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Goldman Sachs Inflation  vs.  Balter Invenomic Fund

Goldman Sachs Inflation

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Goldman Sachs Inflation has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Goldman Sachs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Balter Invenomic

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Balter Invenomic Fund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Balter Invenomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Goldman Sachs and Balter Invenomic

The main advantage of trading using opposite Goldman Sachs and Balter Invenomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goldman Sachs position performs unexpectedly, Balter Invenomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Balter Invenomic will offset losses from the drop in Balter Invenomic's long position.

The idea behind Goldman Sachs Inflation and Balter Invenomic Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.